Hetronifly (serplulimab) - Fosun Pharma
Hercessi (trastuzumab-strf) - Fosun Pharma, Intas, Eurofarma
https://www.prnewswire.com/news-releases/henlius-keeps-steady-growth-in-h1-2025-overseas-product-profits-soar-200-innovation-fuels-global-reach-302537677.html
 
Aug 25, 2025
 
Next